Zhitong Finance App News, China Resources Shuanghe (600062.SH) issued an announcement. Recently, the company received the “Drug Supplement Application Approval Notice” (Notice No.: 2025B00900) issued by the State Drug Administration to increase the specifications of this product (5ml:500mg based on the total amount of active entities of sugenglucosamine and mono-hydroxyglucosamine active entities), and issued a new drug approval number, which is valid for 12 months. The production process for the new specifications is carried out as attached, and the rest is carried out according to the original approved content. The relevant changes shall be implemented within 6 months from the date of approval.

Zhitongcaijing · 03/11 09:17
Zhitong Finance App News, China Resources Shuanghe (600062.SH) issued an announcement. Recently, the company received the “Drug Supplement Application Approval Notice” (Notice No.: 2025B00900) issued by the State Drug Administration to increase the specifications of this product (5ml:500mg based on the total amount of active entities of sugenglucosamine and mono-hydroxyglucosamine active entities), and issued a new drug approval number, which is valid for 12 months. The production process for the new specifications is carried out as attached, and the rest is carried out according to the original approved content. The relevant changes shall be implemented within 6 months from the date of approval.